Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Liposarcoma × 1 year × Clear all

Phase

Status

Recruiting 17 Active not recruiting 11 Completed 9 Terminated 3 Withdrawn 1 Not yet recruiting 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 30 Prostatic Neoplasms 19 Neoplasms 19 Colorectal Neoplasms 17 Carcinoma, Non-Small-Cell Lung 13 Head and Neck Neoplasms 12 Pancreatic Neoplasms 10 Neoplasm Metastasis 10 Melanoma 10 Brain Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Lung Neoplasms 8 Leukemia, Myeloid, Acute 8 Ovarian Neoplasms 7 Carcinoma, Renal Cell 7 Triple Negative Breast Neoplasms 6 Leukemia 6 Hematologic Neoplasms 6 Glioblastoma 6 Carcinoma, Squamous Cell 6 Sarcoma 5 Recurrence 5 Lymphoma, Follicular 5 Endometrial Neoplasms 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Multiple Myeloma 4 Lymphoma 4 Liver Neoplasms 4

Interventions

pembrolizumab 1 olaparib 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06116578 2025-12-01

NeoSarc

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Withdrawn

Liposarcoma, Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡